The information contained in this page is intended for UK healthcare professionals only.
Our surgical care portfolio is comprised of clinically differentiated products used in the operating room and in critical care settings.
The portfolio offers a variety of devices and pharmaceuticals including haemostats and sealants as well as inhaled anaesthetics as Baxter looks to transform surgical efficiency, safety and recovery.
Baxter’s long heritage in maintaining supportive partnerships with clinicians has meant our Biosurgery products have been developed in close collaboration with the very people who will be using them. We are proud to be helping improve clinical outcomes for patients through our range of haemostats and sealants, biological meshes, orthobiologic products and other biosurgery products in the portfolio. In addition, we are able to leverage our relationship with the NHS (spanning nearly half a century) to work with policy makers to develop and support patient safety initiatives.
Anaesthesia and Critical Care
Baxter has a long history in playing a key role in surgical anaesthesia. We are a leading manufacturer of modern inhaled anaesthesia and the first company to offer all three of the most commonly used modern inhaled anaesthetics for general anaesthesia. Our products include inhaled anaesthetics and anaesthesia-related critical care drugs to control heart rate in patients who are at high risk for cardiac events.